TY - JOUR T1 - Management of <em>Helicobacter pylori</em> infection—the Maastricht IV/ Florence Consensus Report JF - Gut JO - Gut SP - 646 LP - 664 DO - 10.1136/gutjnl-2012-302084 VL - 61 IS - 5 AU - Peter Malfertheiner AU - Francis Megraud AU - Colm A O'Morain AU - John Atherton AU - Anthony T R Axon AU - Franco Bazzoli AU - Gian Franco Gensini AU - Javier P Gisbert AU - David Y Graham AU - Theodore Rokkas AU - Emad M El-Omar AU - Ernst J Kuipers AU - The European Helicobacter Study Group (EHSG) Y1 - 2012/05/01 UR - http://gut.bmj.com/content/61/5/646.abstract N2 - Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions. ER -